SCHEMBL21995232

SCHEMBL21995232

CC(C)(C)OC(=O)N1CC(=O)[C@@H](C(=O)C(F)(F)F)C1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 1/20 0.39
DDB1 Q16531 3/20 0.39
CRBN Q96SW2 3/20 0.39
RORC P51449 1/20 0.38
USP2 O75604 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
MAPT P10636 2/20 0.36
KDM4E B2RXH2 2/20 0.36
THRB P10828 1/20 0.36
NAMPT P43490 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC8 Q9BY41 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
CTSK P43235 1/20 0.36
LIPE Q05469 1/20 0.36
MEN1 O00255 1/20 0.36
ALDH1A1 P00352 1/20 0.36
KMT2A Q03164 1/20 0.36
HPGD P15428 1/20 0.35
PREP P48147 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22056023 1.00 NR1H2 (0.39) NR1H2DDB1CRBNRORCUSP2
SCHEMBL1007010 0.86 DDB1 (0.40) NR1H2DDB1CRBNRORCUSP2
SCHEMBL1006353 0.86 KDM4E (0.43) USP2SMN1; SMN2MAPTKDM4ETHRB
SCHEMBL24812373 0.83 NR1H2 (0.42) NR1H2DDB1CRBNRORCUSP2
SCHEMBL27736427 0.83 NR1H2 (0.42) NR1H2DDB1CRBNUSP2SMN1; SMN2
SCHEMBL2732408 0.81 PDE4B (0.43) NR1H2DDB1CRBNUSP2SMN1; SMN2
SCHEMBL28422335 0.79 DDB1 (0.41) NR1H2DDB1CRBNUSP2SMN1; SMN2
SCHEMBL23580148 0.79 NR1H2 (0.41) NR1H2DDB1CRBNRORCUSP2
SCHEMBL954970 0.78 NR1H2 (0.43) NR1H2DDB1CRBNRORCUSP2
SCHEMBL12364068 0.78 NR1H2 (0.40) NR1H2DDB1CRBNRORCUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3887371-A1 ARYL COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF BACTERIAL INFECTION F. Hoffmann-La Roche AG (CH) 2021-10-06 EP disclosed
WO-2020109191-A1 ARYL COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF BACTERIAL INFECTION F. HOFFMANN-LA ROCHE AG (CH) 2020-06-04 WO disclosed